Article
Circulating tumour DNA as a complementary tool for treatment evaluation in HPV-associated Head and neck squamous cell carcinoma: An observational cohort study
2024-09-01
Abstract excerpt
Objectives HPV-positive Oropharyngeal squamous cell carcinoma (OPSCC) and Head and neck carcinoma of unknown primary (HNCUP) is increasing. Despite good prognosis, recurrence rates range from 10- to 25%. Surveillance with clinical controls and imaging are not always reliable. Circulating tumour human papillomavirus DNA (ctHPV-DNA) has emerged as a potential biomarker for treatment evaluation and detection of recur...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8001e104-2825-5ab0-9ddc-3da4717e8ac9
- DOI
- 10.22541/au.172518758.82243109/v1
